FdaApplication
NDA 220106
Identifiers
- fda_app_no: NDA220106
Properties
| Property | Value |
|---|---|
| applicant_name | PRIOVANT THERAP |
| application_type | NDA |
| approval_date | 2026-08-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LISRAYA | BREPOCITINIB TOSYLATE | EQ 30MG BASE | TABLET;ORAL |
1 product